Metadata
Title
Addressing Antimicrobial Resistance through Advanced UTI Models
Category
undergraduate
UUID
a32ceb2855f84769969cc5d64f29a830
Source URL
https://beyondantibiotics.ox.ac.uk/news/addressing-antimicrobial-resistance-thro...
Parent URL
https://beyondantibiotics.ox.ac.uk/
Crawl Time
2026-03-09T03:19:25+00:00
Rendered Raw Markdown

Addressing Antimicrobial Resistance through Advanced UTI Models

Source: https://beyondantibiotics.ox.ac.uk/news/addressing-antimicrobial-resistance-through-advanced-uti-models Parent: https://beyondantibiotics.ox.ac.uk/

28 Nov 2025

Addressing Antimicrobial Resistance through Advanced UTI Models

Bacteria on P-FLO Organoid under Flow Conditions

Urinary tract infections (UTIs) remain a major global health challenge, with high recurrence rates and growing antimicrobial resistance contributing to an estimated 260,000 deaths annually. Current laboratory susceptibility tests often fail to predict real-world treatment outcomes, underscoring the need for physiologically relevant infection models.

Bacteria on P-FLO Organoid

A recent study led by Beyond Antibiotics researcher, Dr Ramon Garcia Maset, in collaboration with Dr Aaron Crowther and Mr Davide De Grandi, who were co-supervised by Prof Jennifer Rohn at University College London and Dr Dario Carugo at the University of Oxford, deploys innovative models as platforms to better replicate the bladder environment:

The team showed that microenvironmental complexity and mechanical forces significantly influenced the behaviour of uropathogenic E. coli and the effectiveness of antibiotics and bacteriophages. While nitrofurantoin showed strong activity in standard assays, it was less effective in advanced models. Similarly, bacteriophage therapy and combination treatments demonstrated variable performance depending on physiological conditions and flow dynamics.

Bacteria and Biofilm on Organoid Model

Implications for Antimicrobial Resistance:

Read the pre-print here: Effect of human urinary microenvironment and fluid flow on antibiotic and phage therapy efficacy against uropathogenic Escherichia coli | bioRxiv

This research is funded by the Engineering and Physical Science Research Council (EPSRC) Programme Grant Scheme under the reference number EP/V026623/1.